Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.09 0.00 (-0.45%)
As of: Sep 30, 2026 · 1:08 PM EDT

Cadrenal Therapeutics, Inc. (CVKD) Operating Expenses (2022 - 2026)

Updated

Cadrenal Therapeutics (CVKD) posted Operating Expenses of $3.34 million for Q2 2026, down 10.5% from $3.73 million a year earlier.

Analysis

Cadrenal Therapeutics, Inc. (CVKD) Operating Expenses (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Cadrenal Therapeutics was $12 million, up 15.2% year-over-year; for FY2023, it came in at $7.63 million, up 182.5% from FY2022.

  • In prior years, Cadrenal Therapeutics' Operating Expenses was $2.7 million in FY2022.
  • The Q2 2026 figure stands as the lowest quarterly Operating Expenses since Q3 2024.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q2 2024, with growth of 140.4%; the weakest was Q1 2024, with a decline of 58.2%.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.34 Mn
Jun 30, 2025 3.73 Mn
Sep 30, 2024 2.46 Mn
Jun 30, 2024 2.47 Mn
Mar 31, 2024 1.76 Mn
Dec 31, 2023 1.26 Mn
Sep 30, 2023 1.14 Mn
Jun 30, 2023 1.03 Mn
Mar 31, 2023 4.20 Mn
Dec 31, 2022 1.08 Mn
Sep 30, 2022 972,791.00
Jun 30, 2022 482,347.00
Mar 31, 2022 170,521.00
API Access

Cadrenal Therapeutics, Inc. Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CVKD&period=max&api_key=YOUR_API_KEY